Skip to main navigation Skip to search Skip to main content

Identification of monogenic variants in steroid-resistant and steroid-sensitive nephrotic syndrome

  • Bshara Mansour
  • , Katharina Lemberg
  • , Ronen Schneider
  • , Ken Saida
  • , Izzeldin Elmubarak
  • , Seyoung Yu
  • , Kirollos Yousef
  • , Camille Nicolas Frank
  • , Korbinian M. Riedhammer
  • , Muhammad Yasir Zahoor
  • , Caroline M. Kolvenbach
  • , Lea M. Merz
  • , Nils D. Mertens
  • , Aaron Bao
  • , Daanya Salmanullah
  • , Gina Kalkar
  • , Selina Hölzel
  • , Elena Zion
  • , Daniel Marchuk
  • , Kraisoon Lomjansook
  • Alina Braun, Gijs A.C. Franken, Loai A. Eid, Hazem Subhi H. Awad, Muna Al Saffar, Neveen A. Soliman, Marwa M. Nabhan, Jameela A. Kari, Sherif El Desoky, Mohamed A. Shalaby, Said Ooda, Hanan M. Fathy, Shrikant Mane, Shirlee Shril, Michael J.G. Somers, Florian Buerger, Friedhelm Hildebrandt
  • Harvard University
  • University of Cologne
  • Technical University of Munich
  • University of Veterinary and Animal Sciences, Lahore, Pakistan
  • Heidelberg University 
  • Leipzig University
  • Al Jalila Children's Specialty Hospital
  • Cairo University
  • Egyptian Group for Orphan Renal Diseases (EGORD)
  • Egypt Center for Research and Regenerative Medicine
  • King Abdulaziz University
  • Alexandria University
  • Farwaniya Hospital
  • Yale University
  • University of Hamburg

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Steroid-resistant nephrotic syndrome (SRNS) constitutes the second most common cause of chronic kidney disease (CKD) in children. A monogenic cause can be identified in approximately 25% of SRNS cases. In contrast, steroid-sensitive or steroid-dependent nephrotic syndrome (SSNS/SDNS) is typically attributed to multifactorial or immunological causes and rarely linked to monogenic etiology. Methods: We performed exome sequencing (ES) in 237 families, including 183 with SRNS and 54 with SSNS/SDNS. Results: A (likely) pathogenic variant in a known SRNS gene was identified in 29/183 individuals with SRNS (15.8%). Additionally, 6/183 (3.3%) individuals with SRNS carried pathogenic variants in phenocopy genes—genes associated with diseases that clinically mimic SRNS. The diagnostic yield was significantly higher in individuals with ≥ 50 Mb homozygosity-by-descent (HBD) (44.7% vs. 8.5%) and in those with SRNS disease onset before 1 year of age (41.9%). In individuals with SSNS/SDNS, we found a likely causative variant in only 1 of 54 probands. Conclusions: A genetic cause was established in 19.1% of SRNS patients (15.8% in known SRNS genes and 3.3% in phenocopy genes), but only 1.9% of non-steroid-resistant cases.

Original languageEnglish
Pages (from-to)1663-1675
Number of pages13
JournalPediatric Nephrology
Volume41
Issue number6
DOIs
StatePublished - Jun 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Exome sequencing (ES)
  • Glomerular disease
  • Monogenic disease
  • Pediatric kidney disease
  • Steroid-resistant nephrotic syndrome (SRNS)

Fingerprint

Dive into the research topics of 'Identification of monogenic variants in steroid-resistant and steroid-sensitive nephrotic syndrome'. Together they form a unique fingerprint.

Cite this